Skip to content-
It’s about time…
Roughly 15 years ago, scientists first mapped the human genome, leading many to believe that this would usher in a new age of personalized therapies to treat cancer and many other diseases. However, [...]
-
Lefkofsky startup takes on cancer
Published in Crain’s Chicago Business, September 29, 2016 – On a shelf behind Eric Lefkofsky’s desk are bound copies of the closing documents of the three companies he’s taken public, Groupon, [...]
-
Tempus
Tempus is a health-tech company that enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. Tempus provides genomic sequencing [...]
-
Tight spaces
Years ago when I was speaking at an engagement, someone asked me how to create good culture, and I responded without hesitation: “you can’t create good culture, but you can create the right [...]
-
We live in the era of insight
The other day, I read an article by Michael Malone in The Wall Street Journal. Two of his quotes stood out: “One of the most extraordinary features of big data is that it signals the end of the reign [...]
-
The Greatest “Fighter” of All Time
I was about to write a blog on the value of insight we can derive from Big Data when I found myself voraciously consuming old Muhammad Ali interviews on YouTube. So I decided to do what I do often – [...]
-
Eric Lefkofsky – Harvard School of Business of Chicago
-
Groupon CEO: We’re in ‘rare air’ with mobile
-
Lightbank
Check out the Lightbank portfolio of companies: www.lightbank.com/portfolio
-
InnerWorkings
InnerWorkings, Inc. (NASDAQ: INWK) is the leading global marketing execution firm serving Fortune 500 brands across a wide range of industries. As a comprehensive outsourced enterprise solution, the [...]